Tracked shipping to Austria with premium packaging for just 3,99 € 

Ship to
Austria
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada novel therapeutics from modern biotechnology
Type
Physical Book
Illustrated by
Publisher
Author
Language
English
Pages
248
Format
Hardcover
Dimensions
23.4 x 15.6 x 1.6 cm
Weight
0.56 kg.
ISBN
3540650253
ISBN13
9783540650256
Categories

novel therapeutics from modern biotechnology

Dale L. Oxender (Illustrated by) · Leonard E. Post (Illustrated by) · Springer · Hardcover

novel therapeutics from modern biotechnology - Oxender, Dale L. ; Post, Leonard E.

Cheaper New Book Imported to Austria
Delivery: 15 Jul - 22 Jul Shipping: 12 to 16 business days.
279,97 €
Faster New Book Imported to Austria
Delivery: 03 Jul - 07 Jul Shipping: 4 to 5 business days.
483,11 €
Import costs and 10% VAT included in the price ✅
279,97 €

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "novel therapeutics from modern biotechnology"

A cover story of Business Week Magazine in January 1984 stated "Biotech Comes of Age". In February 1986, Venture Magazine had a cover article entitled "The Biotech Revolution is Here". This article went on to say "New Genetic Technologies Will Transform Our Lives". These announcements were made many years after the first biotechnology companies, such as Genentech, Cetus, Amgen and Biogen, were formed-to commercialize the "New Biology". . At the time of writing this book, there are over 1300 biotech companies developing new technologies or identifying potential biotech drugs. Most of these companies were started in the height of the "high-technology hype", although companies are still forming as the technology advances. A more recent survey showed only a relatively small number of Food and Drug Administration (FDA) approvals among over several hundred biotech- nology products now in clinical trial. One could ask why it has taken so long to produce biotechnology products. Part of the reason is that each new class of biotech products brings with it a set of problems that need to be solved before they enter clinical trials. These problems are often unique to biotechnology products, such as peptides, proteins, monoclonal antibodies, nucleic acids and cellular therapies.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews